Statistics.
tumor, tumors
TUMOR, TUMORS
A combined analysis of individual patient data from both the initial dose–determination cohort and expansion cohorts was performed. Baseline characteristics and radiation dosimetry were compared between patients in the complete-Rx cohort (all treated tumors received complete coverage by the prescription dose) and the partial-Rx cohort (patients with at least 1 tumor receiving partial coverage by the prescription dose) using 